Back to Agendas
Concurrent Breakout Session 1B: Bayesian Methods for a Better Decision Making Process
Session Chair(s)
Bradley P. Carlin, PhD, MS
Senior Advisor, Data Science and Statistics
PharmaLex, United States
Speaker(s)
CDRH’s Perspective: Bayesian Quantitative Benefit-Risk
Telba Irony, PhD, MS, MSc
Janssen R&D, United States
Senior Scientific Director, Quantitative Sciences
Bayesian Decision Making: Industry‘s Perspective
David Ohlssen, PhD
Novartis Pharmaceuticals Corporation, United States
Senior Expert Methodologist
Bayesian Approach to Personalized Benefit-Risk Assessment: A Perspective
Ram Tiwari, PhD, MS
Bristol Myres Squibb , United States
Head of Statistical Methodology
Panel Discussion
All Session Speakers, United States
Have an account?